|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.10 CNY | +2.01% |
|
+2.33% | -5.83% |
| 03-03 | Gan & Lee Pharmaceuticals Gets Regulatory Nod for Prostate Cancer Drug Trials | MT |
| 01-22 | Gan & Lee Pharmaceuticals Expects 2025 Profit to Jump Up to 95% | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.01% | +2.33% | -3.70% | +0.12% | -5.83% | +36.76% | +77.56% | -48.49% | - | 5.42B | |
| -1.22% | +0.70% | +2.27% | +6.31% | +0.02% | +3.65% | +3.35% | +64.98% | +104.48% | 80.21B | |
| +2.69% | +4.11% | -0.64% | +8.71% | +10.35% | +55.43% | +228.22% | +229.54% | +280.22% | 56.58B | |
| +0.82% | +59.20% | +59.20% | +59.20% | +59.20% | +59.20% | +59.20% | +59.20% | - | 49.5B | |
| -1.49% | -0.33% | -12.88% | -20.37% | -17.52% | -43.48% | -49.72% | -43.92% | +37.47% | 48.23B | |
| +0.09% | +2.39% | -0.31% | +6.12% | +7.06% | +25.01% | -26.56% | -28.25% | -25.23% | 27.63B | |
| -1.36% | +10.34% | +30.92% | +89.39% | +86.44% | +52.89% | -60.24% | -57.63% | - | 22.01B | |
| -1.11% | -2.09% | -4.03% | +0.89% | -2.78% | +34.99% | +33.34% | +22.55% | +39.87% | 19.32B | |
| -0.41% | +10.12% | -4.68% | +2.15% | +12.07% | +114.70% | +117.98% | +8.72% | - | 18.14B | |
| +3.41% | +1.62% | -2.80% | +17.83% | +16.77% | +30.84% | +62.25% | +163.46% | +281.73% | 14.12B | |
| +2.46% | -1.96% | -0.66% | -17.74% | -16.46% | +0.94% | +957.75% | +382.10% | +7,226.83% | 13.27B | |
| +13.22% | +15.17% | +2.55% | +2.23% | -2.84% | +136.69% | +428.59% | +6.60% | - | 12.73B | |
| +0.02% | +4.03% | +2.06% | +13.39% | +2.46% | -15.47% | -32.71% | -21.39% | -27.17% | 11.71B | |
| +1.12% | +1.40% | -9.74% | +11.44% | -8.92% | +40.04% | +184.88% | +159.70% | +2,286.51% | 8.41B | |
| +0.94% | -1.03% | -3.55% | +8.91% | +5.90% | +42.08% | +256.86% | +229.11% | - | 7.56B | |
| +0.53% | +2.12% | -4.77% | -16.55% | -12.06% | -40.83% | -57.31% | -46.77% | - | 7.2B | |
| -1.94% | -2.43% | -13.43% | -9.11% | -9.07% | -3.33% | -5.21% | -49.55% | -50.77% | 7.06B | |
| +1.37% | +12.82% | -8.04% | -19.52% | -8.27% | +160.33% | +181.12% | +195.73% | +126.33% | 6.53B | |
| 0.00% | -0.95% | -1.58% | -3.70% | -1.58% | -9.04% | 0.00% | -19.38% | -70.50% | 5.97B | |
| +0.12% | -4.20% | -10.77% | -36.33% | -31.32% | +109.07% | +667.09% | +609.65% | +470.78% | 5.67B | |
| Average | +1.07% | +2.77% | +0.77% | +5.17% | +4.18% | +39.52% | +151.32% | +90.80% | +821.58% | 21.36B | |
| Weighted average by Cap. | +0.57% | +2.73% | +6.06% | +11.62% | +10.51% | +30.49% | +97.21% | +73.76% | +484.56% |
- Stock Market
- Equities
- 603087 Stock
- Sector Gan & Lee Pharmaceuticals.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition